Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luqing Wei

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|August 14, 2023
Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axisTing Xiao, Dandi Gao, Xiaoting Gu, et al.
Neuroscience Letters|January 18, 2014
Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairmentYanwei Zhang, Xiao Zhang, Jiuquan Zhang, et al.
Brain Research|September 23, 2011
The synchronization of spontaneous BOLD activity predicts extraversion and neuroticismLuqing Wei, Xujun Duan, Yang Yang, et al.
Journal of Affective Disorders|May 21, 2013
Altered brain structural connectivity in post-traumatic stress disorder: a diffusion tensor imaging tractography studyZhiliang Long, Xujun Duan, Bing Xie, et al.
Journal of the Neurological Sciences|May 7, 2014
The pattern of brain gray matter impairments in patients with subcortical vascular dementiaChen Liu, Chuanming Li, Li Gui, et al.
International Immunopharmacology|October 17, 2022
Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathwayShanshan Chen, Yuli Wei, Shimeng Li, et al.
Journal of Cellular and Molecular Medicine|January 18, 2023
Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathwayXiaohe Li, Xiaoyang Ma, Yang Miao, et al.
Respirology (Carlton, Vic.)|April 14, 2025
Add-On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin-Treated Mice and Patients With Pulmonary FibrosisJie Huang, Nana Liu, Yueyue Jin, et al.
European Journal of Pharmacology|January 22, 2023
Vorapaxar proven to be a promising candidate for pulmonary fibrosis by intervening in the PAR1/JAK2/STAT1/3 signaling pathway-an experimental in vitro and vivo studyTing Xiao, Shanfa Ren, Jiali Bao, et al.
International Journal of Biological Sciences|July 7, 2023
FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosisHailong Li, Jinhe Li, Yayue Hu, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|August 14, 2023
Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axisTing Xiao, Dandi Gao, Xiaoting Gu, et al.
Neuroscience Letters|January 18, 2014
Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairmentYanwei Zhang, Xiao Zhang, Jiuquan Zhang, et al.
Brain Research|September 23, 2011
The synchronization of spontaneous BOLD activity predicts extraversion and neuroticismLuqing Wei, Xujun Duan, Yang Yang, et al.
Journal of Affective Disorders|May 21, 2013
Altered brain structural connectivity in post-traumatic stress disorder: a diffusion tensor imaging tractography studyZhiliang Long, Xujun Duan, Bing Xie, et al.
Journal of the Neurological Sciences|May 7, 2014
The pattern of brain gray matter impairments in patients with subcortical vascular dementiaChen Liu, Chuanming Li, Li Gui, et al.
International Immunopharmacology|October 17, 2022
Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathwayShanshan Chen, Yuli Wei, Shimeng Li, et al.
Journal of Cellular and Molecular Medicine|January 18, 2023
Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathwayXiaohe Li, Xiaoyang Ma, Yang Miao, et al.
Respirology (Carlton, Vic.)|April 14, 2025
Add-On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin-Treated Mice and Patients With Pulmonary FibrosisJie Huang, Nana Liu, Yueyue Jin, et al.
European Journal of Pharmacology|January 22, 2023
Vorapaxar proven to be a promising candidate for pulmonary fibrosis by intervening in the PAR1/JAK2/STAT1/3 signaling pathway-an experimental in vitro and vivo studyTing Xiao, Shanfa Ren, Jiali Bao, et al.
International Journal of Biological Sciences|July 7, 2023
FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosisHailong Li, Jinhe Li, Yayue Hu, et al.
Pageof 7